Related references
Note: Only part of the references are listed.GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol
Alyssa S. Laun et al.
ACTA PHARMACOLOGICA SINICA (2019)
New concepts of pain
Anne-Priscille Trouvin et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2019)
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
Gioacchino Calapai et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Therapeutic Approaches for Peripheral and Central Neuropathic Pain
Delia Szok et al.
BEHAVIOURAL NEUROLOGY (2019)
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
Tine van de Donk et al.
PAIN (2019)
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews
W. Haeuser et al.
EUROPEAN JOURNAL OF PAIN (2018)
Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America
Ran Abuhasira et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cannabinoids and Pain: New Insights From Old Molecules
Sonja Vuckovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation
Sabrina Giacoppo et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease
Barth Wilsey et al.
JOURNAL OF PAIN (2016)
Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review
Paula Morales et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy
Mark S. Wallace et al.
JOURNAL OF PAIN (2015)
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)
Mark A. Ware et al.
JOURNAL OF PAIN (2015)
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Barth Wilsey et al.
JOURNAL OF PAIN (2013)
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
Jody Corey-Bloom et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Wei Xiong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
John Peter Zajicek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Mark A. Ware et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Randomized Clinical Trials Presented at the World Congress of Endourology: How Is the Quality of Reporting?
Riccardo Autorino et al.
JOURNAL OF ENDOUROLOGY (2010)
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ronald J. Ellis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Barth Wilsey et al.
JOURNAL OF PAIN (2008)
Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial
D. I. Abrams et al.
NEUROLOGY (2007)
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
H Breivik et al.
EUROPEAN JOURNAL OF PAIN (2006)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
J Killestein et al.
NEUROLOGY (2002)
Share Paper
